Title :

Patient-centred composite scores as tools for assesment of response to biological therapy for paediatric and adult severe asthma

Author(s) :

Khaleva, Ekaterina [Auteur]
Brightling, Chris [Auteur]
Eiwegger, Thomas [Auteur]
Altraja, Alan [Auteur]
Bégin, Philippe [Auteur]
Blumchen, Katharina [Auteur]
Bossios, Apostolos [Auteur]
Bourdin, Arnaud [Auteur]
Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] [PhyMedExp]
ten Brinke, Anneke [Auteur]
Brusselle, Guy [Auteur]
Silvia Bumbacea, Roxana [Auteur]
Bush, Andrew [Auteur]
Casale, Thomas [Auteur]
Clarke, Graham [Auteur]
Chaudhuri, Rekha [Auteur]
Fan Chung, Kian [Auteur]
Coleman, Courtney [Auteur]
Corren, Jonathan [Auteur]
Dahlén, Sven-Erik [Auteur]
Deschildre, Antoine [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital Jeanne de Flandre [Lille]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Djukanovic, Ratko [Auteur]
Eger, Katrien [Auteur]
Exley, Andrew [Auteur]
Fleming, Louise [Auteur]
Fowler, Stephen [Auteur]
Gaillard, Erol [Auteur]
Gappa, Monika [Auteur]
Gupta, Atul [Auteur]
Michael Haitchi, Hans [Auteur]
Hashimoto, Simone [Auteur]
Heaney, Liam [Auteur]
Hedlin, Gunilla [Auteur]
Henderson, Markaya [Auteur]
Hua, Wen [Auteur]
Jackson, David [Auteur]
Karadag, Bülent [Auteur]
Helen Katelaris, Constance [Auteur]
Koh, Mariko [Auteur]
Volkmar Kopp, Matthias [Auteur]
Koppelman, Gerard [Auteur]
Kull, Inger [Auteur]
Kurukulaaratchy, Ramesh [Auteur]
Lee, Ji-Hyang [Auteur]
Mahler, Vera [Auteur]
Mäkelä, Mika [Auteur]
Masoli, Matthew [Auteur]
Mathioudakis, Alexander [Auteur]
Mazon, Angel [Auteur]
Melén, Erik [Auteur]
Milger, Katrin [Auteur]
Moeller, Alexander [Auteur]
Murray, Clare [Auteur]
Nagakumar, Prasad [Auteur]
Nair, Parameswaran [Auteur]
Negus, Jenny [Auteur]
Nieto, Antonio [Auteur]
Papadopoulos, Nikolaos [Auteur]
Paton, James [Auteur]
Pijnenburg, Mariëlle [Auteur]
Pike, Katharine [Auteur]
Porsbjerg, Celeste [Auteur]
Rattu, Anna [Auteur]
Rupani, Hitasha [Auteur]
Rusconi, Franca [Auteur]
Rutjes, Niels [Auteur]
Saglani, Sejal [Auteur]
Seddon, Paul [Auteur]
Siddiqui, Salman [Auteur]
Singer, Florian [Auteur]
Tajiri, Tomoko [Auteur]
Turner, Steve [Auteur]
Upham, John [Auteur]
Vijverberg, Susanne J.H. [Auteur]
Wark, Peter [Auteur]
Wechsler, Michael [Auteur]
Yasinska, Valentyna [Auteur]
Roberts, Graham [Auteur]

Journal title :

European Respiratory Journal

Pages :

Online ahead of print

Publisher :

European Respiratory Society

Publication date :

2024-11-07

ISSN :

0903-1936

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Background We have previously developed Core Outcome Measures sets for Severe Asthma (COMSA) by multi-stakeholder consensus. There are no patient-centred tools to quantify response to biologics for severe asthma. We aimed ...
Show more >Background We have previously developed Core Outcome Measures sets for Severe Asthma (COMSA) by multi-stakeholder consensus. There are no patient-centred tools to quantify response to biologics for severe asthma. We aimed to develop paediatric and adult CompOsite iNdexes For Response in asthMa (CONFiRM) incorporating clinical parameters and patient-reported quality of life (QoL). Methods International expert healthcare professionals (HCPs) and patients with severe asthma were invited to: 1) develop consensus levels of clinically relevant changes for each outcome measure within COMSA; 2) use multicriteria decision analysis to develop the CONFiRM scores and 3) assess their internal validity. A separate group of HCPs evaluated CONFiRM's external validity. Results Five levels of change for each COMSA outcome were agreed. Severe exacerbations and maintenance oral corticosteroids use were rated as most important in determining both paediatric and adult CONFiRM scores. There was strong agreement between HCPs and patients, although patients assigned greater importance to QoL. The CONFiRM score quantified response to a biological from −31 (deterioration) to 69 (best possible response). Paediatric and adult CONFiRMs had good discriminative ability for a sufficient (AUC≥0.92) and a substantial (AUC≥0.95) response to biologics. Both CONFiRMs demonstrated excellent external validity (Spearman correlation coefficients 0.9 and 0.8 for paediatric and adult respectively (p<0.0001)). Conclusions We have developed novel patient-centred paediatric and adult CONFiRMs which include QoL measures. CONFiRMs should allow a more holistic understanding of response for the patient and a standardised assessment of the effectiveness of biologics between studies. Further research is needed to prospectively validate CONFiRM scores.Show less >

Language :

Anglais

Popular science :

Non

Collections :

• Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017

Source :

Harvested from HAL

Submission date :

2024-11-15T03:26:15Z